The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gionco David since 2009.
The trader's CIK number is 1456864.
At the time of the last reporting, Gionco David was the Group VP, CFO of Stemline Therapeutics Inc. (stock ticker symbol STML).
Also see all insider trading activities at Stemline Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | STML | 0 | $0 | 41,894 | $243,002 | 0 | $0 |
| 2019 | STML | 0 | $0 | 23,966 | $274,396 | 0 | $0 |
| 2018 | STML | 0 | $0 | 23,830 | $399,985 | 0 | $0 |
| 2017 | STML | 0 | $0 | 11,195 | $95,574 | 0 | $0 |
| 2016 | STML | 0 | $0 | 4,365 | $21,606 | 0 | $0 |
| 2015 | STML | 0 | $0 | 3,311 | $47,082 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | SVNT | 0 | $0 | 49,436 | $5,280 | 0 | $0 |
| 2011 | SVNT | 0 | $0 | 2,032 | $20,320 | 0 | $0 |
| 2010 | SVNT | 0 | $0 | 4,826 | $61,534 | 0 | $0 |
| 2009 | SVNT | 0 | $0 | 19,898 | $306,410 | 7,500 | $32,400 |
1. Stemline Therapeutics Inc (STML)
2. Savient Pharmaceuticals Inc (SVNT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-04-01 | STML | Sale | 11,524 | 4.79 | 55,199 |
| 2020-03-16 | STML | Sale | 2,849 | 3.88 | 11,054 |
| 2020-03-09 | STML | Sale | 5,011 | 5.08 | 25,455 |
| 2020-03-10 | STML | Sale | 8,846 | 4.92 | 43,522 |
| 2020-02-25 | STML | Sale | 9,147 | 6.43 | 58,815 |
| 2019-12-27 | STML | Sale | 197 | 10.48 | 2,064 |
| 2019-12-26 | STML | Sale | 1,511 | 10.75 | 16,243 |
| 2019-12-24 | STML | Sale | 2,388 | 10.97 | 26,196 |
| 2019-12-23 | STML | Sale | 421 | 10.58 | 4,454 |
| 2019-03-11 | STML | Sale | 13,492 | 11.11 | 149,896 |
| 2019-03-12 | STML | Sale | 530 | 11.05 | 5,856 |
| 2019-03-07 | STML | Sale | 1,381 | 11.32 | 15,632 |
| 2019-02-25 | STML | Sale | 8,563 | 12.03 | 103,012 |
| 2018-03-12 | STML | Sale | 9,183 | 17.74 | 162,906 |
| 2018-03-07 | STML | Sale | 1,413 | 16.56 | 23,399 |
| 2018-02-26 | STML | Sale | 4,400 | 17.61 | 77,484 |
| 2018-02-27 | STML | Sale | 4,584 | 17.26 | 79,119 |
| 2018-01-17 | STML | Sale | 4,250 | 13.43 | 57,077 |
| 2017-03-07 | STML | Sale | 1,116 | 8.13 | 9,073 |
| 2017-02-27 | STML | Sale | 3,500 | 6.97 | 24,395 |
| 2017-02-28 | STML | Sale | 2,986 | 7.01 | 20,931 |
| 2017-01-19 | STML | Sale | 3,593 | 11.46 | 41,175 |
| 2016-03-08 | STML | Sale | 1,148 | 5.32 | 6,107 |
| 2016-01-19 | STML | Sale | 3,171 | 4.82 | 15,284 |
| 2016-01-20 | STML | Sale | 46 | 4.69 | 215 |
| 2015-01-20 | STML | Sale | 3,311 | 14.22 | 47,082 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-10-15 | SVNT | Sale | 47,876 | .08 | 3,830 |
| 2013-03-06 | SVNT | Sale | 1,560 | .93 | 1,450 |
| 2011-01-24 | SVNT | Sale | 2,032 | 10.00 | 20,320 |
| 2010-12-20 | SVNT | Sale | 1,536 | 11.87 | 18,232 |
| 2010-02-16 | SVNT | Sale | 1,253 | 13.81 | 17,300 |
| 2010-02-09 | SVNT | Sale | 2,037 | 12.77 | 26,002 |
| 2009-12-21 | SVNT | Sale | 1,511 | 12.95 | 19,561 |
| 2009-09-15 | SVNT | Option Ex | 7,500 | 4.32 | 32,400 |
| 2009-09-14 | SVNT | Sale | 10,887 | 15.36 | 167,224 |
| 2009-09-15 | SVNT | Sale | 7,500 | 15.95 | 119,625 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gionco David (Group VP, CFO of Stemline Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.